Edwards Lifesciences EW
NYSE EW
$91.36 -0.92 (-1.00%)
At close: Aug 20, 2026 · 11:22 AM UTC

Edwards Lifesciences (EW) Non-Current Deferred Tax Liability (2009 - 2010)

Edwards Lifesciences (EW) posted quarterly Non-Current Deferred Tax Liability of -$21.9 million for Q4 2010, down 16.49% year-over-year from -$26.2 million in Q4 2009, and down 16.49% quarter-over-quarter from -$18.8 million in Q4 2009.

Edwards Lifesciences (EW) Non-Current Deferred Tax Liability (2009 - 2010) Analysis & Trends

Edwards Lifesciences' Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at -$21.9 million for Q4 2010.

  • In Q4 2010, Non-Current Deferred Tax Liability fell 16.49% year-over-year to -$21.9 million; the TTM figure through Dec 2010 stood at -$21.9 million (down 16.49% YoY), while the FY2010 annual figure was -$21.9 million, down 16.49% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2010 stood at -$21.9 million, down from -$18.8 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was -$18.8 million in Q4 2009, with the low at -$21.9 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.50 Bn 194.89 Bn 7.27 Bn
2 Stryker 130.00 Bn 126.52 Bn 4.50 Bn
3 Medtronic 120.36 Bn 111.14 Bn 6.41 Bn
4 Boston Scientific 74.19 Bn 73.65 Bn 3.85 Bn
5 Edwards Lifesciences 52.73 Bn 48.48 Bn 1.35 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn
7 GE HealthCare Technologies 34.13 Bn 32.02 Bn 2.18 Bn
8 Koninklijke Philips 26.52 Bn 23.20 Bn 4.55 Bn
9 Steris 23.23 Bn 22.75 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.39 Bn 18.98 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Dec 31, 2010 -21.90 Mn
Dec 31, 2010 -21.90 Mn
Dec 31, 2009 -18.80 Mn
Dec 31, 2009 -18.80 Mn